UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,686 shares of the healthcare conglomerate’s stock after acquiring an additional 450 shares during the period. Signature Estate & Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,864,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Howard Capital Management Group LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $341,000. Principal Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. Algert Global LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth approximately $1,763,000. Truvestments Capital LLC lifted its stake in UnitedHealth Group by 13.0% in the third quarter. Truvestments Capital LLC now owns 591 shares of the healthcare conglomerate’s stock valued at $346,000 after buying an additional 68 shares during the last quarter. Finally, Mirabella Financial Services LLP acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $235,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.6 %

NYSE:UNH opened at $513.58 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $509.10 and a 200-day simple moving average of $545.56. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a market capitalization of $469.78 billion, a PE ratio of 33.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period last year, the company posted $5.83 EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.